PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.1429
https://www.valueinhealthjournal.com/article/S1098-3015(25)01554-2/fulltext
Title :
PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)01554-2&doi=10.1016/j.jval.2025.04.1429
First page :
Section Title :
Open access? :
No
Section Order :
11129